Joseph Group Capital Management lowered its position in Pfizer Inc. (NYSE:PFE – Free Report) by 95.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,928 shares of the biopharmaceutical company’s stock after selling 58,387 shares during the period. Joseph Group Capital Management’s holdings in Pfizer were […]